Blog - Page 3797 of 5610

MondayApr 12, 2010 9:04 am

Amarillo Biosciences, Inc. (AMAR.OB) Releases Report on Australian Oral Interferon Influenza Study

Amarillo Biosciences, Inc. Friday announced that they have submitted a final report on the recently completed 200 subject low-dose oral interferon (IFN) Phase 2 clinical trial in Perth, Australia and that this report is available for viewing online on the Amarillo website. Dr. Manfred Beilharz, Chair of Microbiology and Immunology, School of Biomedical, Biomolecular and Chemical Sciences, The University of Western Australia, and one of two principal investigators for the study completed the report. Amarillo, in global partnership with the Hayashibara Group, a 6% holder of Amarillo Biosciences, has been steadily moving forward with their research and trials of the…

MondayApr 12, 2010 9:00 am

Cinedigm Digital Cinema Corp. (CIDM) Announces Agreement with Rave Motion Pictures

Cinedigm Digital Cinema Corp. is the global leader in the digital cinema industry. The company provides the services, experience, technology and content to transform movie theaters into digital and networked entertainment centers. Cinedigm works with Hollywood movie studios, independent movie distributors and exhibitors to bring movies in digital cinema format to audiences across the country. The company recently announced that Rave Motion Pictures, a Texas-based cinema chain, has signed an agreement to participate in Cinedigm's Phase 2 digital cinema deployment program. Participating in the program will be Rave's 356 screens across 20 states. All will become Cinedigm Certified digital cinema…

FridayApr 09, 2010 4:09 pm

Vasomedical, Inc. (VASO.OB) Up 343% to a New 52-Week High after Coverage by QualityStocks Newsletter

Vasomedical Inc. rocketed by more than 342.86% today, up $0.24 per share to a price of $0.031 a share. The strong upsurge in the stock's price occurred on massive volume of approximately 8.8 million shares, which is about 5 times the average daily volume. Vasomedical hit a 52-week high today with its intraday high of $0.44 a share, plowing through its previous 52-week high price of $0.105 a share. The company was initially mentioned in QualityStocks Free Daily Newsletter back on April 7, 2009. At that time, the stock was trading for only $0.049 a share. At the current price, shareholders…

FridayApr 09, 2010 11:27 am

Bank of McKenney (BOMK) Reports Strong Increase in Net Income

Bank of McKenney reported net income of $448,000, or $0.24 per diluted share, in the first quarter of 2010. The company earned net income of $278,000, or $0.24 per diluted share, in the same quarter of 2009. The management of Bank of McKenney attributed the strong increase in net income to a deliberate strategy by the bank to lower duration in its investment portfolio in anticipation of a tightening in monetary policy. “This has been an exceptionally profitable quarter for the Bank. In 2007 and 2008, we implemented an investment strategy focused on the unrealistically high yields available in the…

FridayApr 09, 2010 11:26 am

BakBone Software (BKBO.OB) Names Steve Martin Interim CEO and Expects Fourth Quarter Booking to be Within Guidance

Universal Data Management provides a data-centric approach to integrating data protection and improving corporate compliance that allows companies to take the next step towards prominence. Today, BakBone took a step towards enhancing its future by naming an Interim CEO and announcing its fourth quarter bookings. Taking over as BakBone’s Interim CEO is Steve Martin who is the young company’s current CFO. Martin joined BakBone in August of 2008 and has evolved into a respected leader in the industry. Martin replaces James R. Johnson who ceases to be BakBone’s President and CEO after submitting his resignation. In addition to naming Martin…

FridayApr 09, 2010 11:23 am

MMR Information Systems (MMRF.OB) Signs With Chartis to Offer Electronic Personal Health Records Worldwide

MMR Information Systems has been chosen by Chartis Inc., a global property-casualty and general insurance organization serving more than 40 million clients worldwide, to power a system allowing policyholders and their families to access, store, and manage their electronic personal health records and other important documents. Through a strategic alliance with MMR, Chartis will initially offer health records to accident and health policyholders, but is expected to expand the offering to additional product lines in the coming months. The system will be based upon MMR’s MyMedicalRecordsTM technology, and allows records (initially available in 7 different languages) to be accessed and…

FridayApr 09, 2010 11:17 am

Newport Digital Technologies, Inc. (NPDT.OB) Video Chart for Friday, April 9, 2010

Today’s video takes another look at NPDT. It is time to start looking at Newport as a longer term trade as the chart appears to have possibly found a bottom. Watch the video to see what we see. Please click the following link: http://www.qualitystocks.net/videocharts.php?chartvid_id=372 Let us hear your thoughts below:

FridayApr 09, 2010 11:01 am

Inovio Biomedical Corp. (INO) Awarded Grant for Hepatitis C Virus DNA Vaccine Research

Inovio Biomedical Corp. is focused on the design, development and delivery of a new generation of vaccines, called DNA vaccines, to prevent and treat cancers and infectious diseases. The company's SynCon technology enables the design of universal vaccines capable of protecting against multiple strains of pathogens such as influenza. The company announced that it and its team of brilliant researchers and collaborators from Drexel University, Cheyney University and the University of Pennsylvania have received a $2.8 million grant from the Pennsylvania Department of Health to develop a DNA vaccine to treat hepatitis C virus (HCV). The grant will fund pre-clinical…

FridayApr 09, 2010 11:00 am

Avanir Pharmaceuticals Inc. (AVNR) Accepted for “Late Breaking Science” Presentation

As the 2011-12 patent drop-off for a majority of solid selling pharma products approaches, and phase III trial products are watched even more closely by the larger pharma companies, a solid report here or there can only boost value in a company. As the FDA vary rarely telegraphs its likelihood of acceptance for a new drug product, placing an investment on a pharma research company is still a risk. But if the investment pans out, it could provide a very large return. Avanir Pharmaceuticals Inc., a biopharmaceutical company, focuses on acquiring, developing and commercializing drug candidates directed primarily at the…

FridayApr 09, 2010 10:56 am

Sino Clean Energy, Inc. (SCLX) Reports Net Income for 2009 – Raises Guidance for 2010

Sino Clean Energy, Inc. reported adjusted net income of $11.0 million, or $0.11 per share, in 2009. The company earned $5.0 million, or $0.03 per share, in 2008. Sino Clean Energy, Inc. reported a large increase in revenues as well. The company had revenues of $46.0 million in 2009, compared to $14.3 million in 2008. Sino Clean Energy, Inc. said that net income and revenues in 2009 exceeded guidance given by the company. “We are pleased to have exceeded both revenue and net income guidance for 2009, and expect sales of our coal water slurry fuel to continue to increase…

Site Search

Company Search